Joseph K. Belanoff
2017
In 2017, Joseph K. Belanoff earned a total compensation of $4.3M as Chief Executive Officer and President at Corcept Therapeutics, a 78% increase compared to previous year.
Compensation breakdown
| Bonus | $702,000 |
|---|---|
| Option Awards | $2,922,119 |
| Salary | $647,333 |
| Total | $4,271,452 |
Belanoff received $2.9M in option awards, accounting for 68% of the total pay in 2017.
Belanoff also received $702K in bonus and $647.3K in salary.
Rankings
In 2017, Joseph K. Belanoff's compensation ranked 2,350th out of 14,666 executives tracked by ExecPay. In other words, Belanoff earned more than 84.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,350 out of 14,666 | 84th |
Division Manufacturing | 824 out of 5,772 | 86th |
Major group Chemicals And Allied Products | 217 out of 2,075 | 90th |
Industry group Drugs | 166 out of 1,731 | 90th |
Industry Pharmaceutical Preparations | 131 out of 1,333 | 90th |
Source: SEC filing on April 24, 2018.
Belanoff's colleagues
We found four more compensation records of executives who worked with Joseph K. Belanoff at Corcept Therapeutics in 2017.
News
Corcept Therapeutics CEO Joseph Belanoff's 2021 pay jumps 91% to $11M
April 25, 2022
Corcept Therapeutics CEO Joseph Belanoff's 2020 pay rises 16% to $5.8M
April 22, 2021
Corcept Therapeutics CEO Joseph Belanoff's 2019 pay falls 21% to $5M
April 27, 2020
Corcept Therapeutics CEO Joseph Belanoff's 2018 pay jumps 48% to $6.3M
April 24, 2019